You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
CTDetailNew
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Appointment
Find a Condition or Treatment
Find a Doctor
Menu
MAIN
Back to Home
About Us
Corporate Profile
Newsroom
Visitors Information
Contact Us
Patient Care
Specialties & Services
Your Clinic Visit
Cancer Information & Patient Support
E-Services
Find a Doctor
Research & Innovation
Research Labs
Programmes
Facilities
Our Researchers
Clinical Trials
SingHealth Research
Education & Training
Overview
Division of Cancer Education
Events
SingHealth Academy
Careers
Sponsorship
Scholarships
Giving
Why Give
Get Involved
Your Gift at Work
Be Informed
Make a Gift
Our Campaign
Volunteer
Specialties & Services
Back to Home
Goh Cheng Liang Proton Therapy Centre
Haematology
Medical Oncology
Surgery & Surgical Oncology, SGH and NCCS
Radiation Oncology
Oncologic Imaging
Supportive & Palliative Care
Comprehensive Liver Cancer Clinic
Cancer Genetics Service
Lung Multidisciplinary Clinic
Nursing
NCCS Oncology @ SKH
NCCS Oncology Clinic @ CGH
Department of Psychosocial Oncology
Cancer Education and Information
Your Clinic Visit
Back to Home
Book an Appointment
When seeing a doctor
Pharmacy
Outpatient Pharmacy
Oncology Pharmacy
Search a medication
FAQ
Medicine
Charges & Payment
Financial Aid
Video Consultation
Rights & Responsibilities as a Patient
Cancer Information & Patient Support
Back to Home
For Patients
For Caregivers
Publications
Cancer Information Booklets
In Good Health
Inspirational Patient & Caregiver Awards
Patient Stories
E-Services
Back to Home
Make/Change/Cancel Appointment
Request for Medical Report
Health Buddy App
Find a Doctor
Home
to skip to the main content on a page
to skip to the main content on a page
About Us
Back to Home
Corporate Profile
Vision & Mission
NCCS Leadership
Annual Report
Awards
Key Milestones
Whistle-blowing Policy
Newsroom
Press Releases
Check Fake News
Visitors Information
Contact Us
Feedback Form
Patient Liaison Service
Patient Care
Back to Home
Specialties & Services
Goh Cheng Liang Proton Therapy Centre
Haematology
Medical Oncology
Surgery & Surgical Oncology, SGH and NCCS
Radiation Oncology
Oncologic Imaging
Supportive & Palliative Care
Comprehensive Liver Cancer Clinic
Cancer Genetics Service
Lung Multidisciplinary Clinic
Nursing
NCCS Oncology @ SKH
NCCS Oncology Clinic @ CGH
Department of Psychosocial Oncology
Cancer Education and Information
Your Clinic Visit
Book an Appointment
When seeing a doctor
Pharmacy
Medicine
Charges & Payment
Financial Aid
Video Consultation
Rights & Responsibilities as a Patient
Cancer Information & Patient Support
For Patients
For Caregivers
Publications
Patient Stories
E-Services
Make/Change/Cancel Appointment
Request for Medical Report
Health Buddy App
Find a Doctor
Research & Innovation
Back to Home
Research Labs
Cellular & Molecular Research
Medical Sciences
Clinical Trials & Epidemiological Sciences
NCCS Research Committee & Scientific Advisory Board
Research Divisions Organisation Chart
Programmes
Disease Focus
Research Themes
Joint Breast Cancer Registry
Asia-Pacific Hepatocellular Carcinoma Trials Group
The VICTORY Consortium
ANCHOR
Facilities
Overview
Specialised Units
Shared Facilities
Shared Services
Research Contracts and Commercialisation
Our Researchers
Division of Medical Oncology
Division of Surgery & Surgical Oncology, SGH and NCCS
Division of Radiation Oncology
Division of Oncologic Imaging
Division of Supportive and Palliative Care
Cellular and Molecular Research
Division of Medical Sciences
Clinical Trials & Epidemiological Sciences
Research Biennial Book
Clinical Trials
About Clinical Trials
Current Clinical Trials
ECRU
About Clinical Trials & Epidemiological Sciences
Clinical Trials Office
Biostatistics and Epidemiology Unit
SingHealth Research
Education & Training
Back to Home
Overview
Division of Cancer Education
Undergraduate Education Unit
Postgraduate Education Unit
Nursing Education Unit
Faculty Development & Support Education Unit
Primary Care Oncology Education Unit
Communications, Mentoring, Ethics and Professionalism Education Unit
Medical Humanities Education Unit
Events
SingHealth Academy
Careers
Back to Home
Sponsorship
Career Conversion Programme
Scholarships
Giving
Back to Home
Why Give
About Us
Funding Innovative Research
Preventing Cancer
Advancing Medical Education
Helping Our Patients
Furthering Donor Impact
How Your Gift Helps
Get Involved
Honouring Your Gift
Become a Corporate Donor
Leave Your Legacy
Fundraise for Us
Join a Special Event
Your Gift at Work
Stories of Hope
Researchers in Action
Support for Patients
Our Work in the Community
Training Future Experts
Be Informed
Our Publications
Financial Statements
Make a Gift
Our Campaign
Make More Survivors
Jeans For Genes
Women VS Cancer
BCAM 2024
LCAM 2023
Volunteer
Home
>
Patient Care
>
Conditions and Treatment
>
Systemic Sclerosis (Scleroderma)
>
Overview
Facebook
WhatsApp
Email Us
share
Font Resize
A-
A
A+
Print
Systemic Sclerosis (Scleroderma)
Systemic Sclerosis (Scleroderma) - What it is
Scleroderma (also known as systemic sclerosis) literally means “hard skin”. The disorder is characterised by abnormalities of the blood vessels, connective tissue and the immune system. It can affect the skin, digestive system, heart, lungs, muscles and joints.
What causes scleroderma is currently unknown. Some unknown factor triggers an overproduction of collagen (a type of protein that is the main component of the connective tissue) causing thickening, hardening and scarring of the skin and organs throughout the body.
What happens when I have scleroderma?
In scleroderma, the body’s faulty immune system stimulates the fibroblast cells to produce excess collagen. How the body manages and ‘stores’ the excess collagen gives rise to the two major classifications of scleroderma: Limited Scleroderma and Diffuse Scleroderma with different patterns of involvement and symptoms. Let's take a closer look at each of them.
1. Limited scleroderma
In limited scleroderma, the skin involvement is less widespread and is typically confined to the fingers, hands, lower arms, lower legs and the face. Limited scleroderma is sometimes called CREST syndrome, which represents the initial letters of 5 common symptoms:
Calcinosis
: Calcium deposits form under the skin around the elbows, knees or fingers, causing the affected regions of the skin to appear as hard, whitish areas. These deposits can feel tender and sometimes have a tendency to break through the skin, forming painful ulcers.
Raynaud’s phenomenon:
Excess collagen deposits cause narrowing of small blood vessels and decreased blood flow to the extremities, such as the fingers and toes, which often turn white/blue in response to cold temperatures or emotional stress. In extreme cases, this may lead to finger ulcers. Around 90% of patients with limited and diffuse scleroderma will experience this.
Esophageal dysfunction:
When scleroderma involves the muscles of the digestive system, some patients may develop an abnormally wide esophagus, experiencing heartburn, acid reflux, or swallowing difficulties.
Sclerodactyly:
Excess collagen is deposited as areas of thick and shiny skin on the fingers and sometimes the toes. The layer of hard skin often makes it difficult to bend or straighten the fingers.
Telangiectasia
: Small clusters of dilated blood vessels that appear as red spots may develop on the hands and face. These spots are not usually painful, but can cause cosmetic problems.
Limited scleroderma commonly manifests itself slowly over a period of 10 to 20 years. Raynaud’s phenomenon often precedes the skin involvement by many years, followed by other areas of involvement. One of the late manifestations may include heart/ lung involvement called pulmonary arterial hypertension (increased blood pressure in the artery that carries blood from the heart to the lungs).
2. Diffuse scleroderma
Skin involvement in diffuse scleroderma is more widespread and has a much faster onset and progression than limited scleroderma. More importantly, people with diffuse scleroderma have a higher risk of developing hardening of the internal organs such as the lungs, kidneys and heart.
Am I at risk of scleroderma?
Scleroderma is not a common condition. An estimated 20 to 200 people per million are affected worldwide, with the age of onset usually between 30 to 50 years. Women are 4 times more likely to develop the condition than men.
Systemic Sclerosis (Scleroderma) - How to prevent?
Systemic Sclerosis (Scleroderma) - Preparing for surgery
Systemic Sclerosis (Scleroderma) - Post-surgery care
Display Entire Article +
Back
Symptoms
Tags:
Rheumatology & Immunology,
Rheumatology & Immunology,
Connective Tissue Diseases,
Diarrhoea,
High Blood Pressure,
Interstitial Lung Disease,
Pulmonary Arterial Hypertension,
Systemic Sclerosis (Scleroderma),
Antibiotics,
Antihistamines,
Nonsteroidal anti-inflammatory drug,
Prokinetic,
Proton Pump Inhibitor
Article contributed by
Rheumatology & Immunology
,
Singapore General Hospital
The information provided is not intended as medical advice.
Terms of use
. Information provided by
Our Breast Team
Filter:
By designation or sub-specialty
By Designation:
By Sub-Specialty:
TOP
[]
Related Conditions
Connective Tissue Diseases
Pulmonary Arterial Hypertension
High Blood Pressure
Diarrhoea
Interstitial Lung Disease
Systemic Sclerosis (Scleroderma)
View more
Related Medicine
Nonsteroidal anti-inflammatory drug
Antihistamines
Antibiotics
Proton Pump Inhibitor
Prokinetic
View more
×
SUBSCRIBE VIA EMAIL
Subscribe to our mailing list to get the updates to your email inbox...
Find a Doctor
Condition & Treatment
Home
Appointment
E-services